Fig. 2From: The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancera Kaplan-Meier estimates of overall survival (OS) based on neutrophil-to-lymphocyte ratio (NLR) for patient with distal bile duct cancer (log-rank test P < 0.001). b Kaplan-Meier estimates of OS based on lymphocyte-to-monocyte ratio (LMR) for patient with distal bile duct cancer (log-rank test P < 0.001)Back to article page